The Business Research Company's Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, February 24, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!How Has The ERCP Market Size Evolved And What Are The Predicted Growth Trends?
Over the years, the ERCP market size has seen notable growth. Poised to grow from $1.72 billion in 2024 to $1.87 billion in 2025, it underscores a compound annual growth rate CAGR of 8.87%. Such growth can be credited to the rising prevalence of various chronic gastrointestinal diseases, escalating applications of ERCP, an increase in pancreatic cancer instances, government investment spikes, and the rise in medical tourism.
Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20770&type=smp
The ERCP market size is projected to witness substantial growth in the forthcoming years, reaching $2.60 billion by 2029 with a CAGR of 8.58%. Key contributing factors for this substantial growth encompass the growing prevalence of gastrointestinal conditions, rising cancer incidence, amplified focus on investments, a surge in pancreatic duct cases, and the escalating demand for endoscopes.
What Factors Are Propelling The ERCP Market Growth?
The rapidly increasing prevalence of gastrointestinal conditions is poised to fuel the growth of the ERCP market. These conditions encompass a broad array of disorders affecting the gastrointestinal GI tract, extending from the mouth to the anus, and including accessory organs like the liver, gallbladder, and pancreas. The rise in gastrointestinal conditions is attributed to diverse factors such as dietary changes, an aging population, antibiotic use, lifestyle aspects, and environmental influences.
ERCP stands out as a minimally invasive technique to diagnose and treat patients with gastrointestinal conditions as it addresses issues within the bile and pancreatic ducts, including gallstones, strictures, tumors, or infections. For instance, in January 2024, the American Cancer Society reported approximately 26,890 new cases of stomach cancer in the United States, with nearly 10,880 deaths anticipated from this type of cancer. This highlights how the increasing prevalence of gastrointestinal conditions is driving the ERCP market growth.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/endoscopic-retrograde-cholangiopancreatography-ercp-global-market-report
Who Are The Key Players In The ERCP Market?
Prominent companies operating in the ERCP market include Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.
What Major Trends Are Shaping The ERCP Market?
Significant players in the ERCP market concentrate on developing technologically advanced tools, such as the cholangioscope direct visualisation system. This system grants advanced, high-resolution direct visualisation of the bile and pancreatic ducts throughout ERCP procedures. A salient example of such advances is Penlon Limited, a UK-based medical device company that launched the VedVision Cholangioscope Direct Visualisation System in July 2024. This advanced tool facilitates high-resolution, direct visualization of the bile and pancreatic ducts, enhancing ERCP procedures' diagnosis and therapeutic effectiveness.
How Is The ERCP Market Segmented Geographically?
North America held the most substantial share in the ERCP market in 2024, with Asia-Pacific predicted to be the fastest-growing region in the subsequent forecast period. The ERCP market report covers crucial regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Browse For More Similar Reports-
Acute Pancreatitis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/acute-pancreatitis-global-market-report
Pancreatic Cancer Diagnostic Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-diagnostic-global-market-report
Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-epi-therapeutics-and-diagnostics-global-market-report
Insightful strategic market reports like these by The Business Research Company can shape your business decisions, helping you gain competitive advantages across 27 industries spanning 60+ geographies. With over 15000+ reports and 1,500,000 datasets in their repertoire, The Business Research Company provides broad-reaching, data-rich research and insights informed by in-depth secondary research, and exclusive insights from industry leaders.
Get in touch:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us: info@tbrc.info
Stay connected:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn